What you need to know about lecanemab – the Alzheimer’s drug rejected for NHS use
The drug has been developed by Eisai, a Japanese pharmaceutical company, and is sold under the brand name Leqembi
The drug has been developed by Eisai, a Japanese pharmaceutical company, and is sold under the brand name Leqembi